Chang, C.-H., Tsai, W.-C., Hsu, Y.-H., & Su Pang, J.-H
In UK practice, monitoring is primarily based on clinical response rather than routine blood tests, as post-treatment serum B12 measurements can be misleadingly high and may not reflect tissue levels
Youre not the only one wondering what happened
This escalation approach improves tolerability while identifying the minimum effective dose for each individual
BPC-157 reduced elevated portal pressure to normal levels
However, some individuals may experience: Injection site reactions such as mild redness, itching, or swelling Water retention or mild fluid buildup, particularly in the early weeks Joint discomfort or stiffness, which often resolves as the body adjusts Tingling or numbness in the hands or feet (less common) Elevated blood glucose levels in individuals predisposed to insulin resistance It is worth noting that tesamorelin should not be used by individuals with active cancer, those who are pregnant, or patients with hypersensitivity to its components
